Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals.
Wang S, Jiao F, Border JJ, Fang X, Crumpler RF, Liu Y, Zhang H, Jefferson J, Guo Y, Elliott PS, Thomas KN, Strong LB, Urvina AH, Zheng B, Rijal A, Smith SV, Yu H, Roman RJ, Fan F.
Wang S, et al. Among authors: smith sv.
Am J Physiol Heart Circ Physiol. 2022 Feb 1;322(2):H246-H259. doi: 10.1152/ajpheart.00438.2021. Epub 2021 Dec 24.
Am J Physiol Heart Circ Physiol. 2022.
PMID: 34951541
Free PMC article.